128 related articles for article (PubMed ID: 37289474)
1. IRF4/DUSP22-positive anaplastic large cell lymphoma arising in the setting of chronic olecranon bursitis.
Ku A; Alobeid B
Blood; 2023 Jun; 141(23):2912. PubMed ID: 37289474
[No Abstract] [Full Text] [Related]
2.
Wang M; Kibbi N; Ring N; Siddon A; Foss F; Totonchy M
BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31570354
[TBL] [Abstract][Full Text] [Related]
3. Small-cell pattern of DUSP22 rearranged ALK-negative anaplastic large-cell lymphoma with leukemic phase.
Aarakaki H; Karube K
Blood; 2022 Jan; 139(3):465. PubMed ID: 35050329
[No Abstract] [Full Text] [Related]
4. Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma.
Hapgood G; Ben-Neriah S; Mottok A; Lee DG; Robert K; Villa D; Sehn LH; Connors JM; Gascoyne RD; Feldman AL; Farinha P; Steidl C; Scott DW; Slack GW; Savage KJ
Br J Haematol; 2019 Aug; 186(3):e28-e31. PubMed ID: 30873584
[No Abstract] [Full Text] [Related]
5. Primary cutaneous anaplastic large cell lymphoma with DUSP22-IRF4 rearrangement demonstrating a biphasic histopathologic pattern and a complete natural regression.
Kitajima Y; Yamashina M; Hanamoto M; Shijimaya T; Terai S; Nakamaru S; Makimura K; Inoue N; Takeuchi K; Kiyohara T
J Dermatol; 2022 Sep; 49(9):e309-e310. PubMed ID: 35560037
[No Abstract] [Full Text] [Related]
6. Progress in the identification of subgroups in ALK-negative anaplastic large-cell lymphoma.
Boddicker RL; Feldman AL
Biomark Med; 2015; 9(8):719-22. PubMed ID: 26223379
[No Abstract] [Full Text] [Related]
7. Primary cutaneous anaplastic large-cell lymphoma with DUSP22-IRF4 rearrangement following insect bites.
Zhang Y; Chen M; Yu Y; Liu X; Liu W; Jiang L; Zhang W
J Cutan Pathol; 2022 Feb; 49(2):187-190. PubMed ID: 34622970
[TBL] [Abstract][Full Text] [Related]
8.
Savage KJ; Slack GW
Haematologica; 2023 Jun; 108(6):1463-1467. PubMed ID: 36453106
[No Abstract] [Full Text] [Related]
9. DUSP22 rearrangement in primary cutaneous T cell lymphoma with features intermediate between mycosis fungoides, anaplastic large-cell lymphoma and lymphomatoid papulosis.
Diaz de la Pinta FJ; Machan S; Manso Alonso R; Carvajal N; Nieves Salgado R; Piris MA; Rodriguez-Pinilla SM
Histopathology; 2022 Jan; 80(2):446-449. PubMed ID: 34252219
[No Abstract] [Full Text] [Related]
10. [Detection of chromosomal translocations of DUSP22 and TP63 in ALK-negative anaplastic large cell lymphoma by fluorescence in situ hybridization and related clinical relevance].
Wang C; Chen X; Chen XY; He YH
Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):791-795. PubMed ID: 31594044
[No Abstract] [Full Text] [Related]
11. Discovery of G6PD deficiency in a patient with DUSP22-rearranged ALK-negative anaplastic large cell lymphoma in leukemic phase.
Anderson J; Putnam E; Liu W; Menon MP
Int J Lab Hematol; 2022 Feb; 44(1):67-68. PubMed ID: 34019742
[No Abstract] [Full Text] [Related]
12. "Double-hit" of DUSP22 and TP63 rearrangements in anaplastic large cell lymphoma, ALK-negative.
Karube K; Feldman AL
Blood; 2020 Feb; 135(9):700. PubMed ID: 32106310
[No Abstract] [Full Text] [Related]
13. Co-occurring rearrangements of
Klairmont MM; Ward N
Leuk Lymphoma; 2022 Feb; 63(2):506-508. PubMed ID: 34612143
[No Abstract] [Full Text] [Related]
14. Indolent ALK-negative anaplastic large-cell lymphoma, DUSP22 rearranged, with an unusual immunophenotype in a human immunodeficiency virus patient.
Chapman J; Vega F
Histopathology; 2017 Jun; 70(7):1173-1175. PubMed ID: 28042680
[No Abstract] [Full Text] [Related]
15. Primary effusion anaplastic large cell lymphoma with indolent clinical course and IRF4/DUSP22 rearrangement: a case report expanding the spectrum of effusion-based lymphoma.
Yuan CT; Cheng AL; Hou HA
Virchows Arch; 2023 Mar; 482(3):641-645. PubMed ID: 35984488
[TBL] [Abstract][Full Text] [Related]
16.
Onaindia A; de Villambrosía SG; Prieto-Torres L; Rodríguez-Pinilla SM; Montes-Moreno S; González-Vela C; Piris MA
Haematologica; 2019 Apr; 104(4):e158-e162. PubMed ID: 30361415
[No Abstract] [Full Text] [Related]
17. Histopathological features and outcomes of DUSP22 rearrangement in primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature.
Nieto-Benito LM; Parra-Blanco V; Gómez-Navarro Y; Menárguez-Palanca J; Pulido-Pérez A
J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e670-e672. PubMed ID: 34014587
[No Abstract] [Full Text] [Related]
18.
Qiu L; Tang G; Li S; Vega F; Lin P; Wang SA; Wang W; Iyer SP; Malpica L; Miranda RN; Konoplev S; Tang Z; Fang H; Medeiros LJ; Xu J
Haematologica; 2023 Jun; 108(6):1604-1615. PubMed ID: 36453104
[TBL] [Abstract][Full Text] [Related]
19. Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma.
Ravindran A; Feldman AL; Ketterling RP; Dasari S; Rech KL; McPhail ED; Kurtin PJ; Shi M
Am J Surg Pathol; 2021 Apr; 45(4):550-557. PubMed ID: 33165091
[TBL] [Abstract][Full Text] [Related]
20. Systemic ALK-negative anaplastic large cell lymphoma with distinctive myxoid change and DUSP22 rearrangement.
Fratoni S; Trawinska MM; Capalbo A; Bernardini L; Fabbretti M; Martini M; Niscola P; Zhao XF
Virchows Arch; 2022 Dec; 481(6):975-979. PubMed ID: 35879438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]